Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 136

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections

Nguyen, Angela T., Oglesby-Sherrouse, Amanda G. · 2016 · Applied Microbiology and Biotechnology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00253-016-7596-3

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 60

  1. Ahlgren HG, Benedetti A, Landry JS, Bernier J, Matouk E, Radzioch D, Lands LC, Rousseau S, Nguyen D (2015) Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients. BMC Pulm Med 15:67 · DOI
  2. Baldan R, Cigana C, Testa F, Bianconi I, De Simone M, Pellin D, Di Serio C, Bragonzi A, Cirillo DM (2014) Adaptation of Pseudomonas aeruginosa in cystic fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection. PLoS One 9:e89614 · DOI · Paper page
  3. Bouvier NM (2016) Cystic fibrosis and the war for iron at the host-pathogen battlefront. Proc Natl Acad Sci 113:1480–1482. doi: 10.1073/pnas.1525101113 · DOI
  4. Bryan LE, Van Den Elzen HM (1977) Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother 12:163–177 · DOI
  5. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH (1999) Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43:1379–1382 · DOI
  6. Costerton JW (2001) Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 9:50–52 · DOI · Paper page
  7. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM (1995) Microbial biofilms. Annu Rev Microbiol 49:711–745 · DOI · Paper page
  8. DeLeon S, Clinton A, Fowler H, Everett J, Horswill AR, Rumbaugh KP (2014) Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect Immun 82:4718–4728 · DOI · Paper page
  9. Deziel E, Lepine F, Milot S, He J, Mindrinos MN, Tompkins RG, Rahme LG (2004) Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A 101:1339–1344 · DOI · Paper page
  10. Diggle SP, Matthijs S, Wright VJ, Fletcher MP, Chhabra SR, Lamont IL, Kong X, Hider RC, Cornelis P, Camara M, Williams P (2007) The Pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum sensing and iron entrapment. Chem Biol 14:87–96 · DOI · Paper page
  11. Filkins LM, O’Toole GA (2015) Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLoS Pathog 11:e1005258 · DOI · Paper page
  12. Filkins LM, Graber JA, Olson DG, Dolben EL, Lynd LR, Bhuju S, O’Toole GA (2015) Co-culture of Staphylococcus aureus with Pseudomonas aeruginosa drives S. aureus towards fermentative metabolism and reduced viability in a cystic fibrosis model. J Bacteriol 197:2252–2264. doi: 10.1128/JB.00059-15 · DOI · Paper page
  13. Foundation, Cystic Fibrosis (2014) Patient registry annual data report 2014. Cystic Fibrosis Foundation, Bethesda
  14. Fugere A, Lalonde Seguin D, Mitchell G, Deziel E, Dekimpe V, Cantin AM, Frost E, Malouin F (2014) Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients. PLoS One 9:e86705 · DOI · Paper page
  15. Gallagher LA, McKnight SL, Kuznetsova MS, Pesci EC, Manoil C (2002) Functions required for extracellular quinolone signaling by Pseudomonas aeruginosa. J Bacteriol 184:6472–6480 · DOI · Paper page
  16. Gotz F, Mayer S (2013) Both terminal oxidases contribute to fitness and virulence during organ-specific Staphylococcus aureus colonization. Mbio 4:e00976-13 · DOI
  17. Hammer ND, Reniere ML, Cassat JE, Zhang Y, Hirsch AO, Indriati Hood M, Skaar EP (2013) Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host. Mbio 4:e00241-13 · DOI · Paper page
  18. Heeb S, Fletcher MP, Chhabra SR, Diggle SP, Williams P, Camara M (2011) Quinolones: from antibiotics to autoinducers. FEMS Microbiol Rev 35:247–274 · DOI · Paper page
  19. Hoffman LR, Deziel E, D’Argenio DA, Lepine F, Emerson J, McNamara S, Gibson RL, Ramsey BW, Miller SI (2006) Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 103:19890–19895 · DOI · Paper page
  20. Hubert D, Reglier-Poupet H, Sermet-Gaudelus I, Ferroni A, Le Bourgeois M, Burgel PR, Serreau R, Dusser D, Poyart C, Coste J (2013) Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. J Cyst Fibros 12:497–503 · DOI · Paper page
  21. Hunter RC, Asfour F, Dingemans J, Osuna BL, Samad T, Malfroot A, Cornelis P, Newman DK (2013) Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. Mbio 4:e00557-13 · DOI · Paper page
  22. Huse HK, Kwon T, Zlosnik JEA, Speert DP, Marcotte EM, Whiteley M (2010) Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. Mbio 1:e00199-10 · DOI
  23. Konings AF, Martin LW, Sharples KJ, Roddam LF, Latham R, Reid DW, Lamont IL (2013) Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun 81:2697–2704 · DOI · Paper page
  24. Korgaonkar AK, Whiteley M (2011) Pseudomonas aeruginosa enhances production of an antimicrobial in response to N-acetylglucosamine and peptidoglycan. J Bacteriol 193:909–917 · DOI · Paper page
  25. Lechner S, Lewis K, Bertram R (2012) Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol 22:235–244 · DOI
  26. Lightbown JW, Jackson FL (1956) Inhibition of cytochrome systems of heart muscle and certain bacteria by the antagonists of dihydrostreptomycin: 2-alkyl-4-hydroxyquinoline N-oxides. Biochem J 63:130–137 · DOI · Paper page
  27. Lipuma JJ (2010) The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23:299–323 · DOI · Paper page
  28. Lister PD, Wolter DJ, Hanson ND (2009) Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22:582–610 · DOI · Paper page
  29. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265–1273 · DOI · Paper page
  30. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194–222 · DOI · Paper page
  31. Lynch SV, Bruce KD (2013) The cystic fibrosis airway microbiome. Cold Spring Harb Perspect Med 3:a009738 · DOI
  32. Machan ZA, Taylor GW, Pitt TL, Cole PJ, Wilson R (1992) 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother 30:615–623 · DOI · Paper page
  33. Maresso AW, Schneewind O (2006) Iron acquisition and transport in Staphylococcus aureus. Biometals 19:193–203 · DOI · Paper page
  34. Marsland BJ, Gollwitzer ES (2014) Host-microorganism interactions in lung diseases. Nat Rev Immunol 14:827–835 · DOI · Paper page
  35. Martin LW, Reid DW, Sharples KJ, Lamont IL (2011) Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Biometals 24:1059–1067 · DOI
  36. Meyer JM (2000) Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species. Arch Microbiol 174:135–142 · DOI · Paper page
  37. Meyer JM, Stintzi A, De Vos D, Cornelis P, Tappe R, Taraz K, Budzikiewicz H (1997) Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems. Microbiology 143(Pt 1):35–43 · DOI · Paper page
  38. Michelsen CF, Christensen AM, Bojer MS, Hoiby N, Ingmer H, Jelsbak L (2014) Staphylococcus aureus alters growth activity, autolysis, and antibiotic tolerance in a human host-adapted Pseudomonas aeruginosa lineage. J Bacteriol 196:3903–3911 · DOI
  39. Monod J (1949) The growth of bacterial cultures. Annu Rev Microbiol 3:371–394 · DOI · Paper page
  40. Murray JL, Connell JL, Stacy A, Turner KH, Whiteley M (2014) Mechanisms of synergy in polymicrobial infections. J Microbiol 52:188–199 · DOI · Paper page
  41. Nairz M, Schroll A, Sonnweber T, Weiss G (2010) The struggle for iron—a metal at the host-pathogen interface. Cell Microbiol 12:1691–1702 · DOI · Paper page
  42. Nguyen AT, O’Neill MJ, Watts AM, Robson CL, Lamont IL, Wilks A, Oglesby-Sherrouse AG (2014) Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung. J Bacteriol 196:2265–2276. doi: 10.1128/JB.01491-14 · DOI · Paper page
  43. Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48:1429–1449 · DOI · Paper page
  44. Ochsner UA, Vasil AI, Vasil ML (1995) Role of the ferric uptake regulator of Pseudomonas aeruginosa in the regulation of siderophores and exotoxin A expression: purification and activity on iron-regulated promoters. J Bacteriol 177:7194–7201 · DOI · Paper page
  45. Otto BR, Verweij-van Vught AM, MacLaren DM (1992) Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit Rev Microbiol 18:217–233 · DOI · Paper page
  46. Pan XS, Hamlyn PJ, Talens-Visconti R, Alovero FL, Manzo RH, Fisher LM (2002) Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones. Antimicrob Agents Chemother 46:2498–2506 · DOI
  47. Pernet E, Guillemot L, Burgel PR, Martin C, Lambeau G, Sermet-Gaudelus I, Sands D, Leduc D, Morand PC, Jeammet L, Chignard M, Wu Y, Touqui L (2014) Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity. Nat Commun 5:5105 · DOI
  48. Pesci EC, Milbank JB, Pearson JP, McKnight S, Kende AS, Greenberg EP, Iglewski BH (1999) Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 96:11229–11234 · DOI · Paper page
  49. Peters BM, Jabra-Rizk MA, O’May GA, Costerton JW, Shirtliff ME (2012) Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev 25:193–213 · DOI · Paper page
  50. Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG, Sogin ML, O’Toole GA (2013) Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 1:27 · DOI · Paper page
  51. Proctor RA, Kriegeskorte A, Kahl BC, Becker K, Loffler B, Peters G (2014) Staphylococcus aureus small colony variants (SCVs): a road map for the metabolic pathways involved in persistent infections. Front Cell Infect Microbiol 4:99 · DOI · Paper page
  52. Rogers GB, Hoffman LR, Whiteley M, Daniels TW, Carroll MP, Bruce KD (2010) Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends Microbiol 18:357–364 · DOI
  53. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, Surette MG (2008) Discerning the complexity of community interactions using a drosophila model of polymicrobial infections. PLoS Pathog 4:e1000184 · DOI · Paper page
  54. Stacy A, McNally L, Darch SE, Brown SP, Whiteley M (2016) The biogeography of polymicrobial infection. Nat Rev Microbiol 14:93–105 · DOI · Paper page
  55. Ster C, Beaudoin F, Diarra MS, Jacques M, Malouin F, Lacasse P (2010) Evaluation of some Staphylococcus aureus iron-regulated proteins as vaccine targets. Vet Immunol Immunopathol 136:311–318 · DOI
  56. Surette MG (2013) The cystic fibrosis lung microbiome. Am Thorac Soc 11:61–65 · DOI · Paper page
  57. Takase H, Nitanai H, Hoshino K, Otani T (2000) Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice. Infect Immun 68:1834–1839 · DOI · Paper page
  58. Voggu L, Schlag S, Biswas R, Rosenstein R, Rausch C, Gotz F (2006) Microevolution of cytochrome bd oxidase in staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J Bacteriol 188:8079–8086 · DOI · Paper page
  59. Wood TK, Knabel SJ, Kwan BW (2013) Bacterial persister cell formation and dormancy. Appl Environ Microbiol 79:7116–7121 · DOI · Paper page
  60. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, Rau MH, Hansen SK, Folkesson A, Johansen HK, Ciofu O, Hoiby N, Sommer MO, Molin S (2011) Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci U S A 108:7481–7486 · DOI · Paper page

Cited by

See all 136

Metadata

Authors
Nguyen, A. T., & Oglesby-Sherrouse, A. G.
Venue
Applied Microbiology and Biotechnology
Published
2016-05-28
Volume
100
Issue
14
Pages
6141-6148
ISSN
  • 0175-7598
  • 1432-0614
Cited by
136
References
16
Language
en
Licence
Funders
  • University of Maryland School of Pharmacy (Start-up funding)
  • National Institute of General Medical Sciences (T32 GM 066706)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections. https://app.cochat.ai/papers/10.1007/s00253-016-7596-3
The paper
Nguyen, A. T., & Oglesby-Sherrouse, A. G. (2016). Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-016-7596-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.